ASC enhances the cytotoxic effect of a PARP1/2 inhibitor, olaparib, on humanacute myeloid leukemia (AML) cells [52].Probably, this is a case of synthetic lethality: TET-mediated DNA oxidationcaused by ASC sensitizes AML cells to PARP inhibition due to the impossibilityof removing non-canonical bases from DNA. This evidence concerns the gene PARP1 and acute myeloid leukemia.